Medicines Co: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
396.05 Mil |
| Income |
-6.93 Mil |
| Net Profit Margin |
-1.75% |
| Return on Equity |
-2.29% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
7.58 |
| Earnings/Share |
-0.13 |
| Book Value/Share |
5.87 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 99.2 | 79.4 | 66.6 |
| 2nd Qtr | 104.2 | 86.7 | 56.4 |
| 3rd Qtr | 98.8 | 88.1 | 62.2 |
| 4th Qtr | NA | 93.9 | 72.3 |
| Total | 302.2 | 348.2 | 257.5 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.06 | $0.09 | $0.06 |
| 2nd Qtr | $0.07 | $0.08 | $0.02 |
| 3rd Qtr | -$0.06 | -$0.25 | -$0.46 |
| 4th Qtr | NA | -$0.08 | $0.03 |
| Total | -$0.05 | -$0.16 | -$0.35 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 25% | 200% | --- |
| 2nd Qtr | NA | -11% | -67% |
| 3rd Qtr | NA | NA | NA |
| 4th Qtr | NA | 68% | NA |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | 50% |
| 2nd Qtr | -12% | 300% |
| 3rd Qtr | 76% | 46% |
| 4th Qtr | NA | NA |
advertisement
Recent News